Status:
UNKNOWN
Use of Loteprednol for Contact Lens Intolerance and Dryness
Lead Sponsor:
Hom, Milton M., OD, FAAO
Collaborating Sponsors:
Bausch & Lomb Incorporated
Conditions:
Contact Lenses Dryness
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Study of the effects of Loteprednol on CL dryness
Eligibility Criteria
Inclusion
- Between the ages of 18 and over inclusive.
- Males or females
- Any race or ethnic background
- CL history- experienced intolerance and either switched solutions or lenses without satisfactory relief.
- Patient is in generally good \& stable overall health.
- Patient likely to comply with study guidelines \& study visits.
- Informed consent signed.
- OSDI score 18 or higher while wearing lenses
- Unsatisfactory wearing time with contact lenses
Exclusion
- Corneal refractive surgery within 6 months of this study.
- Contact lens use on day of examination.
- Corneal ectasia.
- Current use of Restasis
- Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
- Pregnant or lactating women.
- Ocular pathology (includes glaucoma and cataract) which could impact results and/or place patient at risk.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00817557
Start Date
January 1 2009
End Date
September 1 2009
Last Update
January 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Milton M. Hom, OD, FAAO.
Azusa, California, United States, 91702